Access Bio financials at a glance

+ Portfolio

The revenue of Access Bio is reported as 32.48593 billion Won in the fiscal year 2023. The earnings were 11.38 Won per share in 2023, which was 75.79 lower than 2015. And about -2.41564 billion Won are reported as free cash flow in the financials of Access Bio 2023. Dividends of 0 Won per share were paid to shareholders of Access Bio stock KOSDAQ:A950130 in fiscal 2023.

Forecast

Financials

Year	Year	TTM	2016	2015	2014	2013
Rev.	Revenue	N/A	₩32.49B	₩35.58B	₩33.73B	₩45.84B
GM %	Gross Margin %	56.82%	42.84%	32.46%	47.84%	51.86%
OM	Operating Margin	9.43%	-2.15%	0.02%	7.18%	24.83%
EPS	Earnings Per Share	₩206.25	₩11.38	₩47.00	₩76.98	₩307.00
Div.	Dividends	N/A	₩0.00	₩0.00	₩0.00	₩0.00
PR %	Payout Ratio %	0	0	0	0	0
Sha.	Shares	N/AM	24.85M	136.1M	51.75M	26.83M
OCF	Operating Cash Flow	N/A	₩2.45B	₩2.87B	₩0.00M	₩0.00M
FCF	Free Cash Flow	N/A	₩-8,100.32M	₩-2,002.51M	₩0.00M	₩0.00M
FCFS	Free Cash Flow Per Share	₩-3,869.04	₩-,386.82	₩-,135.64	₩-,303.58	₩-82.91

Access Bio financials at a glance

Financials

Discover